Allergan plc 4
4 · Allergan plc · Filed May 5, 2017
Insider Transaction Report
Form 4
Allergan plcAGN
GALLAGHER MICHAEL R
Director
Transactions
- Tax Payment
Ordinary Shares, par value $0.0001
2017-05-03$243.76/sh−668$162,832→ 2,579 total - Exercise/Conversion
Ordinary Shares, par value $0.0001
2017-05-04$245.25/sh+17,693$4,339,208→ 20,272 total - Exercise/Conversion
Phantom Share Units
2017-05-04−17,693→ 0 totalExercise: $245.25From: 2017-05-04Exp: 2017-05-04→ Ordinary Shares (17,693 underlying)
Holdings
- 1,767(indirect: By Trust)
Ordinary Shares, par value $0.0001
- 10,165(indirect: By Trust)
Ordinary Shares, par value $0.0001
Footnotes (2)
- [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- [F2]Represents the disposition of Phantom Share Units acquired under the Allergan, Inc. Deferred Directors' Fee Program. Per the program terms, the Phantom Share Units were settled 100% in ordinary shares of the Issuer upon termination of the Reporting Person's service on the Issuer's board of directors on May 4, 2017.